Kornitzer Capital Management Inc. KS Buys 9,120 Shares of Cardinal Health, Inc. $CAH

Key Points

• Kornitzer Capital Management increased its stake in Cardinal Health by 100.8% in Q4, buying 9,120 shares to hold 18,164 shares valued at about $3.73M; institutional investors own 87.17% of the stock and Nordea added 494,731 shares to hold 645,436 shares (~$133.74M).
• Cardinal reported Q3 EPS of $3.17, beating estimates and raised FY‑2026 guidance to $10.70–$10.80, and executed an additional $250M buyback while reducing debt; however, revenue missed expectations and GAAP results were hurt by a $184M goodwill impairment, leaving the street with a consensus rating of "Moderate Buy" and a $243.67 target.

Kornitzer Capital Management Inc. KS increased its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 100.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 18,164 shares of the company's stock after purchasing an additional 9,120 shares during the quarter. Kornitzer Capital Management Inc. KS's holdings in Cardinal Health were worth $3,733,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Strategy Asset Managers LLC purchased a new stake in shares of Cardinal Health during the third quarter worth $775,000. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Cardinal Health by 15.3% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 37,833 shares of the company's stock worth $5,938,000 after buying an additional 5,030 shares in the last quarter. Versor Investments LP purchased a new stake in shares of Cardinal Health during the third quarter worth $2,090,000. Atle Fund Management AB grew its holdings in shares of Cardinal Health by 13.1% during the third quarter. Atle Fund Management AB now owns 30,297 shares of the company's stock worth $4,755,000 after buying an additional 3,500 shares in the last quarter. Finally, Nordea Investment Management AB grew its holdings in shares of Cardinal Health by 328.3% during the fourth quarter. Nordea Investment Management AB now owns 645,436 shares of the company's stock worth $133,741,000 after buying an additional 494,731 shares in the last quarter. Institutional investors own 87.17% of the company's stock.

Trending Headlines about Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Q3 non‑GAAP earnings beat estimates and company raised FY‑2026 guidance to $10.70–$10.80, above consensus — the core bullish catalyst. PR Newswire: Q3 Results & Outlook
• Positive Sentiment: Company executed $250M additional share repurchase (bringing FY26 repurchases to $1.0B) and reduced debt — shareholder‑friendly actions that support the share price. PR Newswire: Buybacks & Debt Reduction
• Neutral Sentiment: Wells Fargo cut its price target from $256 to $245 but kept an "overweight" rating, signaling continued analyst confidence despite the trim. Benzinga: Wells Fargo PT Change
• Neutral Sentiment: Full earnings call and transcripts are available for investors who want details on segment performance and management commentary. Yahoo Finance: Earnings Transcript Seeking Alpha: Call Transcript
• Negative Sentiment: Revenue missed expectations ($60.9B reported vs. ~$62.1B est.), which prompted media coverage and short‑term selling pressure despite the EPS beat. Benzinga: Revenue Miss Coverage
• Negative Sentiment: GAAP results were weaker: GAAP operating earnings and GAAP EPS declined, driven in part by a $184M pre‑tax goodwill impairment in the Navista & ION reporting unit — a one‑time charge that reduces headline profitability. PR Newswire: Goodwill Impairment
• Negative Sentiment: Several outlets highlighted the "mixed" nature of the report (EPS/guidance vs. revenue/GAAP weakness), which can increase volatility and keep some investors on the sidelines. CNBC: Mixed Results Coverage

Cardinal Health Trading Up 1.2%

Shares of CAH stock opened at $195.13 on Friday. The company's 50-day moving average price is $213.73 and its 200-day moving average price is $205.82. The stock has a market cap of $45.92 billion, a price-to-earnings ratio of 29.84, a PEG ratio of 1.20 and a beta of 0.53. Cardinal Health, Inc. has a twelve month low of $137.75 and a twelve month high of $233.60.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating the consensus estimate of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to analysts' expectations of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company's revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities research analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st were given a dividend of $0.5107 per share. The ex-dividend date of this dividend was Wednesday, April 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health's payout ratio is presently 29.35%.

Analyst Ratings Changes

CAH has been the subject of a number of research reports. Weiss Ratings reaffirmed a "buy (b)" rating on shares of Cardinal Health in a report on Monday, April 20th. Wall Street Zen raised shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a report on Saturday. Leerink Partners reaffirmed an "outperform" rating and set a $275.00 target price on shares of Cardinal Health in a report on Monday, March 9th. Evercore dropped their target price on shares of Cardinal Health from $260.00 to $240.00 and set an "outperform" rating for the company in a report on Wednesday, April 8th. Finally, Robert W. Baird set a $248.00 target price on shares of Cardinal Health in a report on Friday. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, Cardinal Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $243.67.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.